Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dendritic Cell Vaccine in HER2- Breast Cancer
NCT01431196Phase 2Completed
- Sponsor
- Universidad de Navarra
- Start
- Feb 2011
- Primary completion
- Jun 2012
- Modality
- Whole Cell Cancer Vaccines, Dendritic Cell Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of autologous dendritic cell vaccine (Clinica Universidad de Navarra) in breast cancer, sponsored by Universidad de Navarra. Started Feb 2011; status: completed.
02
Drugs
autologous dendritic cell vaccine (Clinica Universidad de Navarra)
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT01431196.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01431196.